Notice of Public Hearing: NIAID Proposed Reorganization

Issuing agencies

Abstract

Pursuant to the NIH Reform Act of 2006 (42 U.S.C. 281(d)(4)), notice is hereby given that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) will be accepting comments on a proposed reorganization involving the Division of Clinical Research (DCR).

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 167 (Monday, August 31, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 167 (Monday, August 31, 2026)]
[Notices]
[Pages 55891-55892]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-17685]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Public Hearing: NIAID Proposed Reorganization

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the NIH Reform Act of 2006 (42 U.S.C. 281(d)(4)), 
notice is hereby given that the National Institute of Allergy and 
Infectious Diseases (NIAID) of the National Institutes of Health (NIH) 
will be accepting comments on a proposed reorganization involving the 
Division of Clinical Research (DCR).

DATES: Comments regarding this proposed reorganization are best assured 
of having their full effect if received from September 14th, 2026-
September 18th, 2026.

ADDRESSES: Information on the proposed reorganization can be found at: 
<a href="https://www.niaid.nih.gov/about/niaid-organization-DCR">https://www.niaid.nih.gov/about/niaid-organization-DCR</a>. The following 
email address is being provided for comments on the reorganization 
<a href="/cdn-cgi/l/email-protection#cb85828a828f8eb3aea8bebfa2bdae98aeb9bda2a8aeb88ba6aaa2a7e5a5a2a3e5aca4bd"><span class="__cf_email__" data-cfemail="db95929a929f9ea3beb8aeafb2adbe88bea9adb2b8bea89bb6bab2b7f5b5b2b3f5bcb4ad">[email&#160;protected]</span></a>. The Website will be active 
September 14th through September 18th, 2026.

FOR FURTHER INFORMATION CONTACT: For additional questions about this 
proposed reorganization contact: Katherine Beck, Acting Executive 
Officer, National Institute of Allergy and Infectious Diseases, 5601 
Fishers Lane, Rockville, MD 20892.

SUPPLEMENTARY INFORMATION: NIAID's proposal to implement organizational 
changes involving the Division of Clinical Research (DCR). The goal for 
the reorganization is to abolish several offices and the Division of 
Clinical Research (DCR) and realign the clinical operations and 
oversight across multiple NIAID components. The proposed reorganization 
aims to better align with Presidential priorities and to reflect the 
Institute's updated vision and revised mission focus while continuing 
important research to benefit the

[[Page 55892]]

American public with proper oversight and transparency.

John H. Powers III,
Acting Director, National Institute of Allergy and Infectious Diseases.
[FR Doc. 2026-17685 Filed 8-28-26; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>